Literature DB >> 4325316

Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia.

E T Lonergan, M Semar, R B Sterzel, G Treser, M A Needle, L Voyles, K Lange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4325316     DOI： 10.1056/NEJM197106242842503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.

Authors:  Lars P Kihm; Sandra Müller-Krebs; Julia Klein; Gregory Ehrlich; Laura Mertes; Marie-Luise Gross; Antonysunil Adaikalakoteswari; Paul J Thornalley; Hans-Peter Hammes; Peter P Nawroth; Martin Zeier; Vedat Schwenger
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  [Uremic neuropathy in relation duration of dialysis and dialyzer].

Authors:  H Dobbelstein
Journal:  Klin Wochenschr       Date:  1972-05-15

3.  Altered peripheral nerve function resulting from haemodialysis.

Authors:  E Stanley; J C Brown; J S Pryor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-01       Impact factor: 10.154

Review 4.  Methyl group deficiency and guanidino production in uremia.

Authors:  Burton D Cohen
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 5.  Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency.

Authors:  Fernando Scaglia; Brendan Lee
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

6.  Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients.

Authors:  Hamid Moradi; Hamid M Said
Journal:  Kidney Int       Date:  2016-08       Impact factor: 18.998
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.